June 23, 2022, Toronto, ON – JDRF is thrilled to announce that the approximately 300,000 Canadians living with type 1 diabetes (T1D) can now automatically qualify for the federal disability tax credit. The disability tax credit (DTC) is a non-refundable tax credit that helps people with disabilities or their support people/family members reduce the amount […]
Government of Canada Approves $30M Joint Funding for Type 1 Diabetes Research
June 16, 2022 – JDRF Canada celebrates the approval of a joint investment of $30M for the JDRF-CIHR Partnership to Defeat Diabetes. We thank the government for this significant investment that will positively impact the type 1 diabetes (T1D) community. The JDRF-CIHR Partnership to Defeat Diabetes is a landmark collaboration between the Government of Canada, […]
All Canadians with type 1 diabetes could soon access Federal Disability Tax Credit
Unanimous vote of members of the Standing Committee on Finance (FINA) brings equitable access to the Disability Tax Credit closer Thursday June 2, 2022, Toronto, ON – This week we saw a major step forward in the effort to ensure all Canadians living with type 1 diabetes (T1D) can access the federal Disability Tax Credit. […]
2022 Sun Life Walk to Cure Diabetes for JDRF returns in-person in over 30 communities across Canada
Thousands will Step Up to raise funds for type 1 diabetes research TORONTO, ON — June 1, 2022 – The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that brings together the type 1 diabetes (T1D) community to unite and raise funds for T1D research with the goal […]
Prince Edward Island announces coverage for continuous glucose monitoring systems under the Diabetes Glucose Sensor Program
Toronto, ON – The provincial government of Prince Edward Island made a historic announcement today about providing better access to continuous glucose monitoring (CGM) systems for people living with diabetes in the province. Complete public coverage for CGM devices will now be provided for people with type 2 and type 1 diabetes (T1D) age two […]
Temerty Foundation Makes History with $10 Million Gift to JDRF, the Largest Single Donation to Type 1 Diabetes Research in Canada
Toronto, ON – March 30, 2022 – James and Louise Temerty have made a transformational $10 million commitment to help fund JDRF’s efforts to find a cure for type 1 diabetes (T1D). The family’s investment through Temerty Foundation is the largest single gift ever made to T1D research in Canada. This extraordinary donation comes 100 […]
JDRF Canada Sets Out to Make History Again
MEDIA RELEASE As Canada Marks 100th Anniversary of First Successful Injection of Insulin, JDRF Canada Sets Out to Make History Again Five Brave Canadian Volunteers Set to Live Atop a Flagpole for 100 Hours, Raising Funds to Find a Cure for Type 1 Diabetes TORONTO, March 10, 2022 — JDRF Canada, the largest charitable funder […]
In Memoriam
We are deeply saddened by the sudden passing of Andrew McKee, former President and CEO of JDRF Canada. Andrew began his journey with JDRF Canada as a Board member. His passion and dedication led him to assume the role of President and CEO for several years. Through his leadership, he blazed an exciting trail for […]
Ontario announces coverage for continuous glucose monitoring systems under the Assistive Devices Program
Friday, March 4, 2022 Toronto, ON – Today, the Ontario government made an exciting announcement that will provide better access for Ontarians with type 1 diabetes (T1D) to continuous glucose monitoring (CGM) systems. These devices will be covered under Ontario’s Assistive Devices Program (ADP), which also provides coverage for insulin pumps. ADP is available to […]
Helping the diabetes community in Ukraine
Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
JDRF in the United States joining partners to support new affordable insulin project with a focus on the US market.
March 3, 2022 – Statement by Dave Prowten, President and CEO, JDRF Canada JDRF has long supported both public and private sector initiatives to make insulin more affordable to ensure people with type 1 diabetes (T1D) can access the insulin they need to stay alive and healthy until we have cures. Today, just two days […]
Alberta announces new coverage for continuous glucose monitoring (CGM) systems
Wednesday February 2, 2022 – JDRF Canada is excited to share that the Alberta government has announced that they will provide public coverage for continuous glucose monitoring (CGM) systems for people with type 1 diabetes (T1D) who are under the age of 18. To qualify, individuals must be enrolled in the province’s non-group coverage or […]
